NCT06046443Phase 2Completed

A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity

Study sponsor: Rhythm Pharmaceuticals, Inc. · RYTM

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2026-02-09Actual

Enrollment · participants28Actual

Source updated2026-02-12Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-02-12 · 4 fields changed

Participant count type changed

− Before

~~Estimated~~

+ After

Actual

Completion date type changed

− Before

~~Estimated~~

+ After

Actual

Primary completion date changed

− Before

~~31 Jan 2026~~

+ After

9 Feb 2026

Recruitment status changed

− Before

~~Active not recruiting~~

+ After

Completed

Check registry source